Evidence map›Paper›PMID 34330335›Full record

ArticleAddiction science & clinical practice2021

Protecting patients and staff in residential treatment centers during exposure to COVID-19: commentary.

Kimberly A Johnson, Carolyn Keough, Holly Hills, Wouter Vermeer, Rebecca Lengnick-Hall, Moira McNulty, Mark McGovern, Hendricks Brown

Abstract readLetter
In one paragraph

Article in Addiction science & clinical practice, 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.

0numbers the graph read from it
0cells of the map it votes in
1citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

1 citing paper in PubMed.

  1. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

8 authors.

Kimberly A JohnsonCollege of Behavioral and Community Science, Department of Mental Health Law and Policy, University of South Florida, Tampa, FL, USA. kjohnson33@usf.edu.ORCID 0000-0002-2179-5688
Carolyn KeoughOperation PAR Inc, Clearwater, FL, USA.
Holly HillsCollege of Behavioral and Community Science, Department of Mental Health Law and Policy, University of South Florida, Tampa, FL, USA.
Wouter VermeerDepartment of Psychiatry and Behavioral Sciences, Feinberg School of Medicine, Northwestern University, Chicago, IL, USA.
Rebecca Lengnick-HallThe Brown School, Washington University in St. Louis, St. Louis, MO, USA.
Moira McNultyDepartment of Medicine, Section of Infectious Diseases, University of Chicago, Chicago, IL, USA.
Mark McGovernCenter for Behavioral Health Services and Implementation Research, Department of Psychiatry and Behavioral Sciences, Stanford University School of Medicine, Palo Alto, CA, USA.
Hendricks BrownDepartment of Psychiatry and Behavioral Sciences, Feinberg School of Medicine, Northwestern University, Chicago, IL, USA.

Funding

INNOVATIVE IMPLEMENTATION RESEARCH METHODS COREP30DA027828 · NIDA · UNIVERSITY OF MIAMI SCHOOL OF MEDICINE · PI BROWN, C. HENDRICKS, MUSTANSKI, BRIAN · 2011 to 2020
$11.4M
NIDA NIH HHS 5P30DA027828-09NIDA NIH HHS P30 DA027828
6 · The paper itself

Abstract

backgroundThe COVID-19 pandemic has created a crisis in access to addiction treatment. Programs with residential components have been particularly impacted as they try to keep infection from spreading in facilities and contributing to further community spread of the virus. This crisis highlights the ongoing daily trade-offs that organizations must weigh as they balance the risks and benefits of individual patients with those of the group of patients, staff and the community they serve. MAIN BODY: The COVID-19 pandemic has forced provider organizations to make individual facility level decisions about how to manage patients who are COVID-19 positive while protecting other patients, staff and the community. While guidance documents from federal, state, and trade groups aimed to support such decision making, they often lagged pandemic dynamics, and provided too little detail to translate into front line decision making. In the context of incomplete knowledge to make informed decisions, we present a way to integrate guidelines and local data into the decision process and discuss the ethical dilemmas faced by provider organizations in preventing infections and responding to COVID positive patients or staff. CONCLUSION AND COMMENTARY: Provider organizations need decision support on managing the risk of COVID-19 positive patients in their milieu. While useful, guidance documents may not be capable of providing support with the nuance that local data and simulation modeling may be able to provide.

Indexed as

Attitude of Health PersonnelCOVID-19HumansOccupational ExposureProgram EvaluationResidential TreatmentRisk ManagementSubstance-Related Disorders

Identifiers

PMID34330335
PMCPMC8323078

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.